Drinking history does not affect HCV therapy success, study finds

10/15/2012 | PhysiciansBriefing.com

Prior alcohol consumption patterns do not significantly affect the success of hepatitis C treatment using pegylated interferon-alpha and ribavirin, according to research from the Pacific Institute for Research and Evaluation in California. Data showed regardless of drinking history, 45.1% of those with HCV genotype 1, 4 or 6 and 80.2% of patients with genotype 2 or 3 achieved a sustained virological response to the combination treatment.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care